It was shown, that 13% of MSI CRC carried ARID2 variants [55] and studies of intestinal tumour organoids and sporadic colorectal adenomas indicate that ARID2 may function as a TSG [20, 56]. This evidence concerns the gene ARID2 and colorectal carcinoma.